Dr. Michael R. Schoech, M.D.
Hepatology (Transplant Hepatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Cincinnati College of Medicine (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 232
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: University of Cincinnati College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Transplant Hepatology Physician primary
KY license 54799 · OH license 35.098160 -
Gastroenterology Physician
OH license 35.098160 -
Internal Medicine Physician
OH license 35.098160
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Cincinnati Medical Center, LLC Cincinnati, OH
- Uofl Health - Jewish Hospital and Mary & Elizabeth Hospital Louisville, KY
- St Elizabeth Edgewood Edgewood, KY
- University of Louisville Hospital Louisville, KY
Medical groups
- University of Cincinnati Physicians Company LLC (1,506 clinicians)
- University of Louisville Physicians Inc (1,445 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 232
- Services billed
- 550
- Patients’ average age
- 66
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 196 | 133 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 65 | 23 |
| Established patient office or other outpatient visit, 30-39 minutes | 34 | 33 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 24 | 22 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | 11 |
| New patient office or other outpatient visit, 60-74 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tacrolimus Other prescribers in Louisville, KY | 363 |
| Mycophenolate Mofetil Other prescribers in Louisville, KY | 313 |
| Entecavir | 84 |
| Omeprazole Other prescribers in Louisville, KY | 41 |
| Vemlidy (tenofovir alafenamide) | 33 |
| Spironolactone Other prescribers in Louisville, KY | 32 |
| Eliquis (apixaban) Other prescribers in Louisville, KY | 32 |
| Carvedilol Other prescribers in Louisville, KY | 30 |
| Envarsus Xr (tacrolimus) Other prescribers in Louisville, KY | 26 |
| Furosemide Other prescribers in Louisville, KY | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 34 payments worth $41,064 in total to this clinician.
| Madrigal Pharmaceuticals | $40,691 |
|---|---|
| Mallinckrodt Hospital Products Inc. | $174 |
| Novo Nordisk Inc | $125 |
| Gilead Sciences, Inc. | $74.10 |
| Compensation for services other than consulting (speaking, faculty) | $38,058 |
|---|---|
| Food and Beverage | $1,715 |
| Travel and Lodging | $1,292 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Madrigal Pharmaceuticals Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,838 |
| Madrigal Pharmaceuticals Oct 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,515 |
| Madrigal Pharmaceuticals Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,515 |
| Madrigal Pharmaceuticals Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,515 |
| Madrigal Pharmaceuticals Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals May 29, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals Jan 21, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $1,935 |
All 15 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Madrigal Pharmaceuticals Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,515 |
| Madrigal Pharmaceuticals Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,515 |
| Madrigal Pharmaceuticals Oct 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,515 |
| Madrigal Pharmaceuticals Oct 13, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to NEWBURGH, IN | $290 |
| Madrigal Pharmaceuticals Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals Sep 10, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DAYTON, OH | $72.80 |
| Madrigal Pharmaceuticals Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,838 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $454 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $244 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $232 |
| Madrigal Pharmaceuticals Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals May 29, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,548 |
| Madrigal Pharmaceuticals Jan 21, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $1,935 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.